| Time | Session |
|---|
|
09:20
09:45
|
Engineered dendritic cell therapy
|
|
09:45
09:55
|
Proffered Paper: Selected from Abstracts - to be announced in 2025
|
|
09:55
10:20
|
Exploiting immune surveillance to target colorectal cancer
|
|
10:20
10:30
|
Proffered Paper: Selected from Abstracts - to be announced in 2025
|
|
10:30
10:55
|
Translation Dysregulation In Cancer as a Source for Targetable Antigens
|